These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 19933994)
21. Homocysteine and steroids levels in metformin treated women with polycystic ovary syndrome. Vrbíková J; Bicíková M; Tallová J; Hill M; Stárka L Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):74-6. PubMed ID: 11928069 [TBL] [Abstract][Full Text] [Related]
22. The relationship between copper, homocysteine and early vascular disease in lean women with polycystic ovary syndrome. Celik C; Bastu E; Abali R; Alpsoy S; Guzel EC; Aydemir B; Yeh J Gynecol Endocrinol; 2013 May; 29(5):488-91. PubMed ID: 23480818 [TBL] [Abstract][Full Text] [Related]
23. Effect of homocysteine-lowering therapy on arterial elasticity and metabolic parameters in metformin-treated diabetic patients. Mashavi M; Hanah R; Boaz M; Gavish D; Matas Z; Fux A; Shargorodsky M Atherosclerosis; 2008 Aug; 199(2):362-7. PubMed ID: 18206891 [TBL] [Abstract][Full Text] [Related]
24. Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome. Luque-Ramírez M; Mendieta-Azcona C; Alvarez-Blasco F; Escobar-Morreale HF Fertil Steril; 2009 Jun; 91(6):2527-36. PubMed ID: 18565522 [TBL] [Abstract][Full Text] [Related]
25. Metformin improves endothelial function and carotid intima media thickness in patients with PCOS. Kaya MG; Yildirim S; Calapkorur B; Akpek M; Unluhizarci K; Kelestimur F Gynecol Endocrinol; 2015 May; 31(5):401-5. PubMed ID: 25791462 [TBL] [Abstract][Full Text] [Related]
26. Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial. Agarwal N; Rice SP; Bolusani H; Luzio SD; Dunseath G; Ludgate M; Rees DA J Clin Endocrinol Metab; 2010 Feb; 95(2):722-30. PubMed ID: 19996308 [TBL] [Abstract][Full Text] [Related]
27. Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction. Pepene CE; Ilie IR; Marian I; Duncea I Eur J Endocrinol; 2011 Jan; 164(1):61-8. PubMed ID: 20974706 [TBL] [Abstract][Full Text] [Related]
28. Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking. Luque-Ramírez M; Mendieta-Azcona C; del Rey Sánchez JM; Matíes M; Escobar-Morreale HF Eur J Endocrinol; 2009 Mar; 160(3):469-80. PubMed ID: 19139031 [TBL] [Abstract][Full Text] [Related]
29. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. Title LM; Cummings PM; Giddens K; Genest JJ; Nassar BA J Am Coll Cardiol; 2000 Sep; 36(3):758-65. PubMed ID: 10987596 [TBL] [Abstract][Full Text] [Related]
30. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785 [TBL] [Abstract][Full Text] [Related]
31. Metformin improves endothelial function in normoinsulinemic PCOS patients: a new prospective. Romualdi D; Costantini B; Selvaggi L; Giuliani M; Cristello F; Macrì F; Bompiani A; Lanzone A; Guido M Hum Reprod; 2008 Sep; 23(9):2127-33. PubMed ID: 18567896 [TBL] [Abstract][Full Text] [Related]
32. Effect of 3 y of folic acid supplementation on the progression of carotid intima-media thickness and carotid arterial stiffness in older adults. Durga J; Bots ML; Schouten EG; Grobbee DE; Kok FJ; Verhoef P Am J Clin Nutr; 2011 May; 93(5):941-9. PubMed ID: 21430116 [TBL] [Abstract][Full Text] [Related]
33. Effect of homocysteine-lowering therapy on vascular endothelial function and exercise performance in coronary patients with hyperhomocysteinaemia. Dinckal MH; Aksoy N; Aksoy M; Davutoglu V; Soydinc S; Kirilmaz A; Dinckal N; Akdemir I Acta Cardiol; 2003 Oct; 58(5):389-96. PubMed ID: 14609303 [TBL] [Abstract][Full Text] [Related]
34. Oral folate enhances endothelial function in hyperhomocysteinaemic subjects. Bellamy MF; McDowell IF; Ramsey MW; Brownlee M; Newcombe RG; Lewis MJ Eur J Clin Invest; 1999 Aug; 29(8):659-62. PubMed ID: 10457148 [TBL] [Abstract][Full Text] [Related]
35. Effect of Sclerovit on endothelial dysfunction, hemorheological parameters, platelet aggregation, plasma concentration of homocysteine and progression of atherosclerosis in patients with vascular diseases. Horvath B; Szapary L; Debreceni L; Feher G; Kenyeres P; Fulop A; Battyani I; Toth K Clin Hemorheol Microcirc; 2009; 42(1):19-28. PubMed ID: 19363237 [TBL] [Abstract][Full Text] [Related]
36. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. Woo KS; Chook P; Lolin YI; Sanderson JE; Metreweli C; Celermajer DS J Am Coll Cardiol; 1999 Dec; 34(7):2002-6. PubMed ID: 10588216 [TBL] [Abstract][Full Text] [Related]
37. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure? Thambyrajah J; Landray MJ; McGlynn FJ; Jones HJ; Wheeler DC; Townend JN Circulation; 2000 Aug; 102(8):871-5. PubMed ID: 10952955 [TBL] [Abstract][Full Text] [Related]
38. Effect of Metformin on Microvascular Endothelial Function in Polycystic Ovary Syndrome. Heidari B; Lerman A; Lalia AZ; Lerman LO; Chang AY Mayo Clin Proc; 2019 Dec; 94(12):2455-2466. PubMed ID: 31806099 [TBL] [Abstract][Full Text] [Related]
39. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome. Sahin Y; Unluhizarci K; Yilmazsoy A; Yikilmaz A; Aygen E; Kelestimur F Clin Endocrinol (Oxf); 2007 Dec; 67(6):904-8. PubMed ID: 17666089 [TBL] [Abstract][Full Text] [Related]
40. The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial. Bahmani F; Karamali M; Shakeri H; Asemi Z Clin Endocrinol (Oxf); 2014 Oct; 81(4):582-7. PubMed ID: 24628390 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]